Erratum: Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study (Endocr 33:1 (9-20) DOI: 10.1007/s12020-008-9044-3);Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study

Endocrine

Volumn 33, Issue 1, 2008, Pages 9-20

  Erem, Cihangir ^a   Hacihasanoglu, Arif ^a   Deger, Orhan ^a   Topbaş, Murat ^a   Hosver, Ilgin ^a   Ersoz, Halil Onder ^a   Can, Gamze ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Associated risk factors; Metabolic syndrome; Prevalence; Trabzon; Turkish population

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; DEMOGRAPHY; DIABETES MELLITUS; EDUCATION; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; SMOKING; SOCIOECONOMICS; TURKEY (REPUBLIC);

EID: 46149089635     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-009-9147-5     Document Type: Erratum

References (48)

1. P.J. Miranda, R.A. DeFronzo, R.M. Califf, J.R. Guyton, Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149, 33-45 (2005)
2. E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416-422 (1991)
3. A. Fontbonne, Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37, 953-955 (1994)
4. R.L. Hanson, G. Imperatore, P.H. Bennett, W.C. Knowler, Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51, 3120-3127 (2002)
5. B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683-689 (2001)
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). JAMA. 285, 2486-2497 (2001)
7. S.W. Oh, Y.S. Yoon, E.S. Lee, W.K. Kim, Association between cigarette smoking and metabolic syndrome. Diabetes Care 28, 2064-2066 (2005)
8. Y.S. Yoon, S.W. Oh, H.W. Baik, H.S. Park, W.Y. Kim, Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 80, 217-224 (2004)
9. S. Yoo, T. Nicklas, T. Baranowski, I.F. Zakeri, S.J. Yang, S.R. Srinivasan, G.S. Berenson, Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: Bogalusa Heart Study. Am. J. Clin. Nutr. 80, 841-848 (2004)
10. C.L. Scott, Diagnosis, prevention and intervention for the metabolic syndrome. Am. J. Cardiol. 92(Suppl), 35i-42i (2003)
11. A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, Y.A. Kesaniemi, Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245, 163-174 (1999)
12. A.J. Cameron, J.E. Shaw, P.Z. Zimmet, The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. N. Am. 33, 351-375 (2004)
13. A. Gupta, R. Gupta, M. Sarna, S. Rastogi, V.P. Grupta, K. Kothari, Prevalence of diabetes, impaired fasting glucose and insulin resistence syndrome in an urban Indian population. Diabetes Res. Clin. Pract. 61, 69-76 (2003)
14. E.S. Ford, W.H. Giles, W.H. Dietz, Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356-359 (2002)
15. B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel, S. Vol, J. Ticket, E. Eschwege, The D.E.S.I.R study group, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29, 526-532 (2003)
16. A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian Adults-a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60, 199-204 (2003)
17. C. Erem, C. Arslan, A. Hacihasanoglu, O. Deger, M. Topbaş, K. Ukinc, H.Ö. Ersöz, M. Telatar, Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes. Res. 12, 1117-1127 (2004)
18. C. Erem, R. YIldIz, H. KavgacI, C. Karahan, O. Deǧer, G. Çan, M. Telatar, Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon City). Diabetes Res. Clin. Pract. 54, 203-208 (2001)
19. I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, The TURDEP Group, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25, 1551-1556 (2002)
20. A. Onat, K. Ceyhan, O. Basar, S. Toprak, V. Sansoy, Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 165, 285-292 (2002)
21. A.K. Ozsahin, A. Gökcel, N. Sezgin, M. Akbaba, N. Güvener, I. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17, 230-234 (2004)
22. M.I. Schmidt, B.B. Duncan, R.L. Watson, A.R. Sharrett, F.L. Brancati, G. Heiss, A metabolic syndrome in whites and African-Americans: the atherosclerosis risk in communities baseline study. Diabetes Care 19, 414-418 (1996)
23. K. Gu Dongfeng Reynolds, X. Wu, J. Chen, X. Duan, R.F. Reynolds, P.K. Whelton, J. He, The interASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in Chine. Lancet 365, 1398-1405 (2005)
24. L.N.T.D. Son, D. Kunii, N.T.K. Hung, T. Sakai, S. Yamamoto, The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res. Clin. Pract. 67, 243-250 (2005)
25. F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res. Clin. Pract. 61, 29-37 (2003)
26. V.G. Athyros, V.I. Bouloukos, A.N. Pehlivanidis, A.A. Papageorgiou, S.G. Dionysopoulou, A.N. Symeonidis, D.I. Petridis, M.I. Kapousouzi, E.A. Satsoglou, Mikhailidis DP, The MetS-Greece Collabotarive Group, The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study. Diabetes Obes. Metab. 7, 397-405 (2005)
27. F.E.R. Punzalan, R.G. Sy, T. Ty-Willing, Prevalence of metabolic syndrome among adult Filipinos. Int. Congr. Ser. 1262, 442-445 (2004)
28. R. Gupta, P.C. Deedwania, A. Gupta, S. Rastogi, R.B. Panwar, K. Kothari, Prevalence of metabolic syndrome in an Indian urban population. Int. J. Cardiol. 97, 257-261 (2004)
29. W.-Y. Lee, J.-S. Park, S.-Y. Noh, E.-J. Rhee, S.-W. Kim, P.Z. Zimmet, Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res. Clin. Pract. 65, 143-149 (2004)
30. R. Miccoli, C. Bianchi, L. Odoguardi, G. Penno, F. Caricato, M.G. Giovannitti, L. Pucci, S. Del Prato, Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15, 250-254 (2005)
31. H.S. Park, S.W. Oh, S.-I. Cho, W.H. Choi, Y.S. Kim, The metabolic syndrome and associated lifestyle factors among South Korean adults. Int. J. Epidemiol. 33, 328-336 (2004)
32. C.A. Aguilar-Salinas, R. Rojas, F.J. Gomez-Perez, V. Valles, J.M. Rios-Torres, A. Franco, G. Olaiz, J.A. Rull, J. Sepulveda, High prevalence of metabolic syndrome in Mexico. Arch. Med. Res. 35, 76-81 (2004)
33. J.-Y. Oh, Y.S. Hong, Y.-A. Sung, E. Barrett-Connor, Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Dibetes Care 27, 2027-2032 (2004)
34. WHO, Obesity: preventing and managing the global epidemic (WHO, Geneva, 1998)
35. J. Lidfeldt, P. Nyberg, C. Nerbrand, G. Samsione, B. Schersten, C.D. Agardh, Socio-demogaphic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes. Metab. 5, 106-112 (2003)
36. S.P. Wamala, J. Lynch, M. Horsten, M.A. Mittleman, K. Schenck-Gustafsson, K. Orth-Gomer, Education and the metabolic syndrome in women. Diabetes Care 22, 1999-2003 (1999)
37. R. Choiniere, P. Lafontaine, A.C. Edwards, Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. Can. Med. Assoc. J. 162, S13-S24 (2000)
38. A.M. Rissanen, M. Heliovaara, P. Knekt, A. Reunanen, A. Aromaa, Determinants of weight gain and overweight in adult Finns. Eur. J. Clin. Nutr. 45, 419-430 (1991)
39. Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 163, 427-436 (2003)
40. T.M. Tahtinen, M.J. Vanhala, J.A. Oikarinen, S.M. Keinanen-Kiukaanniemi, Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J. Cardiovasc. Risk. 5, 319-323 (1998)
41. S. Attvall, J. Fowelin, I. Lager, H. Von Schenck, U. Smith, Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J. Intern. Med. 233, 327-332 (1993)
42. F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Chen, G.M. Reaven, Insulin resistance and cigarette smoking. Lancet 339, 1128-1130 (1992)
43. C. Kong, L. Nimmo, T. Elatrozy, V. Anyaoku, C. Hughes, S. Robinson, W. Richmond, R.S. Elkeles, Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 156, 373-378 (2002)
44. A.S. Leon, J. Connett, D.R. Jacobs Jr., R. Rauramaa, Leisure-time physical activity levels and risk of coronary heart disease and death: the Multiple Risk Factor Intervention Trial. JAMA 258, 2388-2395 (1987)
45. J. Pekkanen, B. Marti, A. Nissinen, J. Tuomilehto, S. Punsar, M.J. Karvonen, Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 255, 1473-1477 (1987)
46. P.S. Denker, V.E. Pollock, Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152, 1649-1651 (1992)
47. World Health Organization, The World Health Report 2000: Health System Efficiency (WHO, Geneva, 2000)
48. R. Ross, D. Dagnone, P.J. Jones, H. Smith, A. Paddags, R. Hudson, I. Janssen, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, cotrolled trial. Ann. Intern. Med. 133, 92-103 (2000)